# Vivo Ventures: portfolio, investments and team > Vivo Ventures is a vc firm based in Brazil. 50 investments on record, 1 in the last 12 months, latest Jul 2026. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/vivo-ventures (Millionrounds; every figure on the page links to its filing or article) Brazil · [Investor](https://millionrounds.com/investors) # Vivo Ventures Last cheque observed Jul 2026; 50 cheques on record. Email Deploying now New fund $6.4M, Jan 2012 VC firm Series A Series B Series D Venture Capital & Private Equity Follow Vivo Ventures and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fvivo-ventures) Deploying now **50%** of best year **1** **cheques in 12 months**, 50 on record Since the last cheque **93** days **00** hrs **00** min **00** sec Median round **$7.0M** Rounds led **1 of 50** Sole investor **3 rounds** Exits **7 from the portfolio** Mostly in **United States, 93%** Pitch Vivo Ventures ## Vivo Ventures highlights - 01 1 cheques in the last 12 months - 02 Mostly Series A and Series B: 46% of its rounds - 03 Sole investor in 3 rounds, median $30M - 04 7 exits from the portfolio ## What they do - **Type:** VC firm (from a list, unverified) - **Cheque size:** Not stated - **Sectors:** Venture Capital & Private Equity - **Based in:** Sao Paulo, Brazil - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **50 appearances** - **2026** 1 round - **Jul** **[Inspira](https://millionrounds.com/company/inspira)** Series A · BR · LatamList **$2.8M** With 1 other - **2024** 2 rounds - **Dec** **[Klubi](https://millionrounds.com/company/klubi)** Series A · BR · LatamList **$7.0M** *Led* - **Oct** **[Agrolend](https://millionrounds.com/company/agrolend)** Series C · BR · SP Ventures **$53M** With 10 others - **2014** 5 rounds - **Oct** **[Aclaris Therapeutics](https://millionrounds.com/company/aclaris-therapeutics)** Series B · US **$21M** With 3 others - **Sept** **[AirXpanders](https://millionrounds.com/company/airxpanders)** Series E · US **$1.0M** With 3 others - **Apr** **[ProNAi Therapeutics](https://millionrounds.com/company/pronai-therapeutics)** Series D · US **$60M** With 8 others - **Apr** **[Nora Therapeutics](https://millionrounds.com/company/nora-therapeutics)** Series B · US **$18M** With 4 others - **Apr** **[Eiger BioPharmaceuticals](https://millionrounds.com/company/eiger-biopharmaceuticals)** Series A · US **$5.8M** With 1 other - **2013** 4 rounds - **Nov** **[Ocera Therapeutics](https://millionrounds.com/company/ocera-therapeutics)** Venture · US · fiercebiotech.com **$28M** With 7 others - **Jul** **[TRIA Beauty](https://millionrounds.com/company/tria-beauty)** Growth · US · pevc.dowjones.com **$46M** With 6 others - **Jun** **[AirXpanders](https://millionrounds.com/company/airxpanders)** Series E · US · t.co **$9.0M** With 3 others - **Jan** **[Carbylan Therapeutics](https://millionrounds.com/company/carbylan-therapeutics)** Series B · US · altapartners.com **$6.0M** With 2 others - **2012** 7 rounds - **Oct** **[Aclaris Therapeutics](https://millionrounds.com/company/aclaris-therapeutics)** Series A · US · finsmes.com **$21M** With 3 others - **Oct** **[TRIA Beauty](https://millionrounds.com/company/tria-beauty)** Venture · US **$7.5M** With 3 others - **Jun** **[Ceptaris Therapeutics](https://millionrounds.com/company/ceptaris-therapeutics)** Series D · US · finsmes.com **$10M** With 5 others - **Jun** **[SentreHEART](https://millionrounds.com/company/sentreheart)** Series C · US · finsmes.com **$26M** With 2 others - **Apr** **[AirXpanders](https://millionrounds.com/company/airxpanders)** Series D · US **$11M** With 4 others - **Jan** **[AirXpanders](https://millionrounds.com/company/airxpanders)** Series D · US · researchviews.com **$1.1M** With 2 others - **Jan** **[AirXpanders](https://millionrounds.com/company/airxpanders)** Growth · US **$10M** With 4 others - **2011** 7 rounds - **Nov** **[Medley Health](https://millionrounds.com/company/medley-health)** Series A · US · sec.gov **$20M** With 2 others - **Nov** **[Medley Health](https://millionrounds.com/company/medley-health)** Series B · US · finsmes.com **$20M** With 2 others - **Nov** **[Rempex Pharmaceuticals](https://millionrounds.com/company/rempex-pharmaceuticals)** Series B · US · rempexpharma.com **$68M** With 4 others - **Aug** **[Yaupon Therapeutics](https://millionrounds.com/company/yaupon-therapeutics)** Series D · US · finsmes.com **$14M** With 3 others - **Jun** **[Revance Therapeutics](https://millionrounds.com/company/revance-therapeutics)** Series D · US · finsmes.com **$45M** With 6 others - **Feb** **[TRIA Beauty](https://millionrounds.com/company/tria-beauty)** Venture · US **$26M** With 3 others - **Jan** **[NextWave Pharmaceuticals](https://millionrounds.com/company/nextwave-pharmaceuticals)** Series C · US · finsmes.com **$45M** With 7 others - **2010** 4 rounds - **Nov** **[Revance Therapeutics](https://millionrounds.com/company/revance-therapeutics)** Series D · US · sec.gov **$36M** With 4 others - **Sept** **[TRIA Beauty](https://millionrounds.com/company/tria-beauty)** Venture · US · finsmes.com **$16M** With 3 others - **Jun** **[Vicept Therapeutics](https://millionrounds.com/company/vicept-therapeutics)** Series A · US · vicepttx.com **$16M** With 4 others - **Jan** **[Neomend](https://millionrounds.com/company/neomend)** Series D · US · finsmes.com **$30M** With 4 others - **2009** 2 rounds - **Jun** **[Sagent Pharmaceuticals](https://millionrounds.com/company/sagent-pharmaceuticals)** Series A · US · onbiovc.com **$30M** Sole investor - **Feb** **[Eiger BioPharmaceuticals](https://millionrounds.com/company/eiger-biopharmaceuticals)** Series A · US · venturebeat.com **$8.3M** With 1 other - **2008** 4 rounds - **Sept** **[APT Pharmaceuticals](https://millionrounds.com/company/apt-pharmaceuticals)** Series A · US · aptbio.com **$32M** With 6 others - **Sept** **[Sagent Pharmaceuticals](https://millionrounds.com/company/sagent-pharmaceuticals)** Series A · US **$30M** Sole investor - **Aug** **[InteKrin](https://millionrounds.com/company/intekrin)** Series C · US · deals.venturebeat.com **$19M** With 6 others - **Jul** **[TRIA Beauty](https://millionrounds.com/company/tria-beauty)** Series E · US **$30M** With 1 other - **2007** 9 rounds - **Dec** **[Revance Therapeutics](https://millionrounds.com/company/revance-therapeutics)** Series C · US **$43M** With 5 others - **Nov** **[Carbylan Therapeutics](https://millionrounds.com/company/carbylan-therapeutics)** Series B · US · carbylan.com **$20M** With 2 others - **Nov** **[Yaupon Therapeutics](https://millionrounds.com/company/yaupon-therapeutics)** Series C · US **$15M** With 1 other - **Oct** **[APT Pharmaceuticals](https://millionrounds.com/company/apt-pharmaceuticals)** Series A · US **$22M** With 3 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team Named by the firm itself, on a filing, its Form ADV or its company registration **3 named** AC **Albert Cha** A Managing Member of the General Partners i Filing they signed EE **Edgar Engleman** A Managing Member of the General Partners i Filing they signed FK **Frank Kung** A Managing Member of the General Partners i Filing they signed ## Exits from the portfolio Companies it backed that were later bought or listed **7 in all** **[Eiger BioPharmaceuticals](https://millionrounds.com/company/eiger-biopharmaceuticals)** Bought by Celladon **Undisclosed** Nov 2015 **[Rempex Pharmaceuticals](https://millionrounds.com/company/rempex-pharmaceuticals)** Bought by The Medicines Company **$464M** Dec 2013 **[Ceptaris Therapeutics](https://millionrounds.com/company/ceptaris-therapeutics)** Bought by Actelion Pharmaceuticals **$250M** Jul 2013 **[Neomend](https://millionrounds.com/company/neomend)** Bought by C. R. Bard **$140M** Oct 2012 **[NextWave Pharmaceuticals](https://millionrounds.com/company/nextwave-pharmaceuticals)** Bought by [Pfizer](https://millionrounds.com/fund/pfizer) **Undisclosed** Oct 2012 **[AgraQuest](https://millionrounds.com/company/agraquest)** Bought by Bayer - Germany **$425M** Jul 2012 **[Vicept Therapeutics](https://millionrounds.com/company/vicept-therapeutics)** Bought by [Allergan](https://millionrounds.com/fund/allergan) **$275M** Jul 2011 An exit counts when it came after the firm's first round in the company. From historical deal records. New fund on file **$6.4M** raised in Jan 2012 From its SEC filing, not a journalist: a firm that has just raised has money to deploy. ## The cheque Series A Series B Series D Median round joined **$7.0M** the round, not its cheque Alone, median **$30M** Led 1 of 50 rounds **2%** - **Sole investor:** 3 rounds - **Last cheque:** Jul 2026 - **Exits:** 7 from the portfolio Rounds by stage said on their site - Series A *12* - Series B *10* - Series D *9* - Series C *8* - Venture *6* - Series E *3* Cheques by month Led Joined Nov 2023 Oct 2026 Often in the room with - [Sofinnova Investments](https://millionrounds.com/fund/sofinnova-investments) 9 - [Technology Partners](https://millionrounds.com/fund/technology-partners) 8 - [InterWest Partners](https://millionrounds.com/fund/interwest-partners) 7 - [Aisling Capital](https://millionrounds.com/fund/aisling-capital) 6 - [GBS Ventures](https://millionrounds.com/fund/gbs-venture-partners) 5 - [Palo Alto Investors](https://millionrounds.com/fund/palo-alto-investors) 5 **Pitching Vivo Ventures?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Vivo Ventures. A count of rooms they were both in, not a relationship either has claimed. [**Sofinnova Investments** VC firm **9** rounds together](https://millionrounds.com/fund/sofinnova-investments)[**Technology Partners** Hedge fund **8** rounds together](https://millionrounds.com/fund/technology-partners)[**InterWest Partners** VC firm **7** rounds together](https://millionrounds.com/fund/interwest-partners)[**Aisling Capital** Private equity **6** rounds together](https://millionrounds.com/fund/aisling-capital)[**GBS Ventures** VC firm **5** rounds together](https://millionrounds.com/fund/gbs-venture-partners)[**Palo Alto Investors** Growth equity **5** rounds together](https://millionrounds.com/fund/palo-alto-investors)[**Prolog Ventures** VC firm **5** rounds together](https://millionrounds.com/fund/prolog-ventures)[**De Novo Ventures** Growth equity **4** rounds together](https://millionrounds.com/fund/de-novo-ventures)[**Essex Woodlands Healthcare Partners** VC firm **4** rounds together](https://millionrounds.com/fund/essex-woodlands-health-ventures)[**F-Prime Capital** VC firm **4** rounds together](https://millionrounds.com/fund/f-prime)[**Fidelity Biosciences** Investment firm **4** rounds together](https://millionrounds.com/fund/fidelity-biosciences)[**OrbiMed** Private equity **4** rounds together](https://millionrounds.com/fund/orbimed) ## Recently backed The latest companies Vivo Ventures put money into. [**Inspira** $2.8M · Jul 2026](https://millionrounds.com/company/inspira)[**Klubi** $7.0M · Dec 2024](https://millionrounds.com/company/klubi)[**Agrolend** $53M · Oct 2024](https://millionrounds.com/company/agrolend) ## Quick answers about Vivo Ventures ### What does Vivo Ventures invest in? Vivo Ventures invests most often at Series A and Series B (46% of the rounds on record), in sectors such as Venture Capital & Private Equity. ### How active is Vivo Ventures? 50 investments on record, 1 of them in the last 12 months, and it led 1. The most recent was in Jul 2026. ### What has Vivo Ventures invested in recently? Its most recent investments on record: Inspira (Series A, Jul 2026), Klubi (Series A, Dec 2024) and Agrolend (Series C, Oct 2024). ### How big are Vivo Ventures's cheques? The median round it joins is $7.0M. ### Does Vivo Ventures lead rounds? Sometimes: it led 1 of its 50 investments on record (2%). ### Where does Vivo Ventures invest? Most of the companies it backs are in the United States (93%) and Brazil (8%). ### Is Vivo Ventures investing now? Yes: it is actively investing, with 1 investments in the last 12 months. ### Who does Vivo Ventures invest alongside? Most often Sofinnova Investments (9 rounds together), Technology Partners (8 rounds together) and InterWest Partners (7 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=vivo-ventures) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=vivo-ventures)